ADC Therapeutics S.A. (ADCT)
NYSE · Healthcare
ADC Therapeutics S.A. Net Income 2022–2025
ADC Therapeutics S.A. annual/quarterly net income history and growth rate from 2022 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- ADC Therapeutics S.A. net income for the quarter ending March 31, 2026 was -33.0 M, a 14.60% decrease year-over-year.
- ADC Therapeutics S.A. net income for the twelve months ending March 31, 2026 was -169.2 M, a 2.68% decrease year-over-year.
- ADC Therapeutics S.A. annual net income for 2025 was -142.6 M, a 9.64% decrease from 2024.
- ADC Therapeutics S.A. annual net income for 2024 was -157.8 M, a 34.25% decrease from 2023.
- ADC Therapeutics S.A. annual net income for 2023 was -240.1 M, a 52.78% increase from 2022.
- ADC Therapeutics S.A. annual net income for 2022 was -157.1 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
ADC Therapeutics S.A. Net Income — FAQ
ADC Therapeutics S.A. (ADCT) net income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is ADC Therapeutics S.A.'s net income?
ADC Therapeutics S.A. (ADCT) reported net income of -$143M for fiscal 2025.
Where can I see ADCT's net income history?
The chart and table above show ADC Therapeutics S.A.'s net income by year and by quarter, including the growth rate.